Biomarin Pharmaceutical Inc (BMRN)
65.58
-1.08
(-1.62%)
USD |
NASDAQ |
Nov 14, 16:00
65.58
0.00 (0.00%)
After-Hours: 20:00
Biomarin Pharmaceutical Gross Profit (Annual): 1.904B for Dec. 31, 2023
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.904B |
| December 31, 2022 | 1.612B |
| December 31, 2021 | 1.376B |
| December 31, 2020 | 1.336B |
| December 31, 2019 | 1.345B |
| December 31, 2018 | 1.176B |
| December 31, 2017 | 1.072B |
| December 31, 2016 | 907.23M |
| December 31, 2015 | 737.89M |
| December 31, 2014 | 627.02M |
| December 31, 2013 | 460.09M |
| December 31, 2012 | 408.89M |
| December 31, 2011 | 357.34M |
| Date | Value |
|---|---|
| December 31, 2010 | 305.98M |
| December 31, 2009 | 258.75M |
| December 31, 2008 | 243.98M |
| December 31, 2007 | 103.22M |
| December 31, 2006 | 75.47M |
| December 31, 2005 | 23.04M |
| December 31, 2004 | 14.69M |
| December 31, 2003 | |
| December 31, 2002 | |
| December 31, 2001 | |
| December 31, 2000 | |
| December 31, 1999 | |
| December 31, 1998 | 1.90M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
1.336B
Minimum
2020
1.904B
Maximum
2023
1.515B
Average
1.376B
Median
2021
Gross Profit (Annual) Benchmarks
| Merck & Co Inc | 43.99B |
| Bristol-Myers Squibb Co | 34.31B |
| Alnylam Pharmaceuticals Inc | 1.518B |
| Repligen Corp | 284.84M |
| Bioventus Inc | 328.19M |